CRH: Other company developments

Item 8.01 Other Events. Offering of U.S. Dollar Guaranteed Notes On November 9, 2026, CRH America Finance, Inc. (“CRH AF”), a wholly owned subsidiary of CRH public limited company (“CRH plc”), completed the issuance and sale of the securities described below pursuant to an underwriting agreement, dated as of November 4, 2026, between CRH plc, CRH AF and Barclays Capital Inc., J.P. Morgan Securities LLC, and Morgan Stanley & Co. LLC, as representatives of the several underwriters named therein (the “Underwriting Agreement”). Pursuant to the Underwriting Agreement, CRH AF agreed to issue and sell to the underwriters named therein (i) $1,350,000,000 aggregate principal amount of 5.375% Guaranteed Notes due 2032 (the “2032 Notes”), (ii) $1,000,000,000 aggregate principal amount of 5.625% Guaranteed Notes due 2034 (the “2034 Notes”), (iii) $1,350,000,000 aggregate principal amount of 5.750% Guaranteed Notes due 2037 (the “2037 Notes”) and (iv) $500,000,000 aggregate principal amount of 6.250% Guaranteed Notes due 2057 (the “2057 Notes” and, together with the 2032 Notes, 2034 Notes, and 2037 Notes, the “Notes”), fully and unconditionally guaranteed by CRH plc as to the principal, interest, premium, if any, and any other amounts payable in respect of them. The Notes were issued in an offering registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and issued pursuant to an Indenture, dated as of May 21, 2024, between CRH plc, CRH AF and The Bank of New York Mellon, as trustee (the “Indenture”), and an officer’s certificate, dated as of November 9, 2026, by CRH AF and CRH plc with respect to the Notes (the “Officer’s Certificate”). The net proceeds of the offering of Notes are expected to be used to finance tender offers made by CRH AF for outstandi